Methylenedioxycyclopropylmethylamphetamine

Methylenedioxycyclopropylmethylamphetamine
Names

Preferred IUPAC name N-(Cyclopropylmethyl)-1-(2H-1,3-benzodioxol-5-yl)propan-2-amine
Identifiers
CAS Number	22698-08-4^Y
3D model (JSmol)	Interactive image
ChemSpider	21106332^N
PubChem CID	71308239
UNII	X8VGM9CN9J^Y
CompTox Dashboard (EPA)	DTXSID60745440
InChI InChI=1S/C14H19NO2/c1-10(15-8-11-2-3-11)6-12-4-5-13-14(7-12)17-9-16-13/h4-5,7,10-11,15H,2-3,6,8-9H2,1H3^N Key: AEIQNPMGFQNZNV-UHFFFAOYSA-N^N InChI=1/C14H19NO2/c1-10(15-8-11-2-3-11)6-12-4-5-13-14(7-12)17-9-16-13/h4-5,7,10-11,15H,2-3,6,8-9H2,1H3 Key: AEIQNPMGFQNZNV-UHFFFAOYAQ
SMILES C3OC1C(C=CC(=C1)CC(C)NCC2CC2)O3
Properties
Chemical formula	C₁₄H₁₉NO₂
Molar mass	233.31 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is ^YN ?) Infobox references

Chemical compound

MDCPM, or 3,4-methylenedioxy-N-cyclopropylmethylamphetamine, is a lesser-known psychedelic drug. It is the N-cyclopropylmethyl derivative of MDMA. MDCPM was first synthesized by Alexander Shulgin; it is also one of the compounds delineated in a patent by Horrom in 1972.^[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 10 mg, and the duration unknown. MDCPM produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDCPM.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

References

^ U.S. patent 3,689,504
^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.